Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

HERO Study Investigators; Neal Shore; Bryan Selby; Xiaolin Fan; Vicky Kang; Jackie Walling; Bertrand Tombal; Teuvo Tammela; Fred Saad; Michael Cookson; Daniel George; Daniel Saltzstein; Ronald Tutrone; Hideyuki Akaza; Alberto Bossi; David van Veenhuyzen; Timo Marttila

doi:10.1056/NEJMoa2004325

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

HERO Study Investigators
, Neal Shore
, Bryan Selby
, Xiaolin Fan
, Vicky Kang
, Jackie Walling
, Bertrand Tombal
, Teuvo Tammela
, Fred Saad
, Michael Cookson
, Daniel George
, Daniel Saltzstein
, Ronald Tutrone
, Hideyuki Akaza
, Alberto Bossi
, David van Veenhuyzen
, Timo Marttila

Research output: Contribution to journal › Article › Scientific › peer-review

419 Citations (Scopus)

Original language	English
Pages (from-to)	2187-2196
Journal	New England Journal of Medicine
Volume	382
Issue number	23
DOIs	https://doi.org/10.1056/NEJMoa2004325
Publication status	Published - 2020
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publication forum classification

Publication forum level 3

Access to Document

10.1056/NEJMoa2004325

http://urn.fi/URN:NBN:fi:tuni-202008146479

Cite this

HERO Study Investigators, Shore, N., Selby, B., Fan, X., Kang, V., Walling, J., Tombal, B., Tammela, T., Saad, F., Cookson, M., George, D., Saltzstein, D., Tutrone, R., Akaza, H., Bossi, A., van Veenhuyzen, D., & Marttila, T. (2020). Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. New England Journal of Medicine, 382(23), 2187-2196. https://doi.org/10.1056/NEJMoa2004325

@article{263bfc77b4d4489a8f7498b97dd479df,

title = "Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer",

author = "\{HERO Study Investigators\} and Neal Shore and Bryan Selby and Xiaolin Fan and Vicky Kang and Jackie Walling and Bertrand Tombal and Teuvo Tammela and Fred Saad and Michael Cookson and Daniel George and Daniel Saltzstein and Ronald Tutrone and Hideyuki Akaza and Alberto Bossi and \{van Veenhuyzen\}, David and Timo Marttila",

year = "2020",

doi = "10.1056/NEJMoa2004325",

language = "English",

volume = "382",

pages = "2187--2196",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "23",

}

HERO Study Investigators, Shore, N, Selby, B, Fan, X, Kang, V, Walling, J, Tombal, B, Tammela, T, Saad, F, Cookson, M, George, D, Saltzstein, D, Tutrone, R, Akaza, H, Bossi, A, van Veenhuyzen, D & Marttila, T 2020, 'Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer', New England Journal of Medicine, vol. 382, no. 23, pp. 2187-2196. https://doi.org/10.1056/NEJMoa2004325

TY - JOUR

T1 - Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

AU - HERO Study Investigators

AU - Shore, Neal

AU - Selby, Bryan

AU - Fan, Xiaolin

AU - Kang, Vicky

AU - Walling, Jackie

AU - Tombal, Bertrand

AU - Tammela, Teuvo

AU - Saad, Fred

AU - Cookson, Michael

AU - George, Daniel

AU - Saltzstein, Daniel

AU - Tutrone, Ronald

AU - Akaza, Hideyuki

AU - Bossi, Alberto

AU - van Veenhuyzen, David

AU - Marttila, Timo

PY - 2020

Y1 - 2020

U2 - 10.1056/NEJMoa2004325

DO - 10.1056/NEJMoa2004325

M3 - Article

SN - 0028-4793

VL - 382

SP - 2187

EP - 2196

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 23

ER -